Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019033257) NEW USE OF COMPOUND FOR INTERFERING WITH SAICAR SYNTHETASE ACTIVITY
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/033257 International Application No.: PCT/CN2017/097467
Publication Date: 21.02.2019 International Filing Date: 15.08.2017
IPC:
C07K 7/00 (2006.01) ,A61P 35/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
7
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
广州君赫生物科技有限公司 GENEHEAL BIOTECHNOLOGY CO., LTD. [CN/CN]; 中国广东省广州市 高新技术产业开发区科学城揽月路3号广州国际企业孵化器G区G105房 Room G105, Zone G, Guangzhou International Business Incubator, No.3, Lanyue Road Science City, Hi-Tech Industrial Development Zone Guangzhou, Guangdong 510000, CN
Inventors:
孙奋勇 SUN, Fenyong; CN
潘武广 PAN, Wuguang; CN
朱威 ZHU, Wei; CN
赵德志 ZHAO, Dezhi; CN
Agent:
广州嘉权专利商标事务所有限公司 JIAQUAN IP LAW FIRM; 中国广东省广州市 天河区黄埔大道西100号富力盈泰广场A栋910张萍 ZHANG, Ping No.910, Building A, Winner Plaza No.100, West Huangpu Avenue, Tianhe District Guangzhou, Guangdong 510627, CN
Priority Data:
Title (EN) NEW USE OF COMPOUND FOR INTERFERING WITH SAICAR SYNTHETASE ACTIVITY
(FR) NOUVELLE UTILISATION DE COMPOSÉ INTERFÉRANT AVEC L'ACTIVITÉ DE LA SAICAR SYNTHÉTASE
(ZH) 化合物干扰SAICAR合成酶活性的新应用
Abstract:
(EN) Disclosed is the use of a compound, such as DrugBank ID DB01864 or DB03295, in the preparation of a SAICAR synthetase activity disrupter or inhibitor, in a treatment or relieving drug for a tumour, or in a treatment or relieving drug for ADSL deficiency.
(FR) L'invention concerne l'utilisation d'un composé, tel que celui sous ID DB01864 ou DB03295 de la DrugBank, dans la préparation d'un perturbateur ou d'un inhibiteur de l'activité de SAICAR synthétase, dans un médicament de traitement ou de soulagement d'une tumeur, ou dans un médicament de traitement ou de soulagement pour une déficience en ADSL.
(ZH) 本申请公开了化合物,如DrugBank ID DB01864或DB03295在制备SAICAR合成酶活性干扰剂或抑制剂,肿瘤治疗或缓解药物,ADSL缺陷症治疗或缓解药物中的应用。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)